C. W. Rivero et al. / Bioorg. Med. Chem. Lett. 22 (2012) 6059–6062
6061
Table 1
Biosynthesis of 6-halogenated purine nucleosides using G. stearothermophilus CECT 43
as biocatalyst
Sugar
donor
6-Halogenated
purine base
Reaction
time (h)
Conversionb
(%)
Productivity
(mM/h)
a
dUrd
Urd
dUrd
Urd
dUrd
Urd
6ChPur
6ChPur
6BrPur
6BrPur
6IPur
2
8
4
8
24
8
90
68
60
50
85
65
0.90
0.17
0.30
0.13
0.07
0.16
6IPur
10
Reactions were performed at least three times with 1 ꢀ 10 CFU at 30 °C in
potassium phosphate buffer (30 mM, pH 7) and 200 rpm using 6 mM base/2 mM
nucleoside ratio. 6ChPur: 6-chloropurine, 6IPur: 6-iodopurine and 6BrPur: 6-
bromopurine.
a
The best times of reaction are shown.
b
mmol product
Conversion (%) =
ꢁ 100.
mmol limiting reagent
Figure 4. 6ChPurdRib productivity using different initial molar ratios of substrates.
10
Reactions were performed during 1 h (white) and 2 h (gray) with 1 ꢀ 10 CFU at
3
0 °C in potassium phosphate buffer (30 mM, pH 7) and 200 rpm using 6ChPur and
0
activity (less than 50% of initial activity) before 12 reuses (see Sup-
plementary data).
We selected this biocatalyst to perform a preliminary test for
bioprocess scale-up. These trials were conducted in a 10 ml batch
reactor in the conditions previously optimized and the results were
similar to those obtained at microscale.
dUrd at different ratios (base/2 -deoxyriboside). All reactions were performed three
times and productivity was calculated relative to the limiting reagent concentra-
tion. Significant differences at 1 h ( P <0.001) or 2 h ( P <0.001) of reaction respect
⁄
⁄⁄
to other ratios.
This difference could be due to an excess of 6ChPur that shifts the
equilibrium favoring 6ChPurdRib formation, since the modified
base competes more effectively against natural purines within
microorganisms.
Currently, environmental factor (E-factor) values to produce
these compounds by pharmaceutical companies vary from 25 to
1
5
1
00. However, the use of safe microorganisms, the characteristics
of the matrix and the simple recovery of excess substrates favor E-
factor decrease more than 10-fold.
Once the reaction parameters were optimized, we evaluated the
0
biosynthesis of different 6-halogenated purine ribo- and 2 -deoxy-
In this report, a new green bioprocess for 6-halogenated purine
nucleosides production has been described by direct transglycosy-
lation using G. stearothermophilus CETC 43 immobilized in an agar-
ose matrix. This biocatalyst meets the requirements of high
activity, stability and short reaction times needed for low cost pro-
duction in a future preparative application using an environmen-
tally friendly methodology.
ribosides using 6-chloro, 6-bromo and 6-iodopurine as starter pur-
ine bases and dUrd or Urd as sugar donors. Quantitative analysis
was carried out by HPLC and product identification was performed
by MS-HPLC under the above mentioned conditions. 6ChPurRib
+
+
+
(
M : 287.5), 6IPurdRib (M : 327.1), 6IPurRib (M : 343.0), 6BrPur-
+
+
dRib (M : 316.2) and 6BrPurRib (M : 332.2). We were able to obtain
acceptable productivity for subsequent bioprocess scale-up. How-
ever, a higher conversion was obtained when dUrd was used as su-
0
Acknowledgments
gar donor instead Urd, because 2 -deoxyriboside hydrolysis was
greater. G. stearothermophilus strain CECT43 was able to synthesize
0
This research was supported by Agencia Nacional de Promoción
Científica y Tecnológica and Universidad Nacional de Quilmes. J A
T, J E S and M E L are research members at CONICET; C W R and
E C D are CONICET fellows, Argentina.
6
-halogenated purine ribosides and 2 -deoxyribosides with a con-
version greater than 50% in all cases (Table 1). The presence of
two PNPs (PNPI and PNPII) in G. stearothermophilus could account
9
for the acceptance of different purine bases. In conclusion, we have
been able to prepare a broad spectrum of different 6-halogenated
purine nucleoside analogues reaching significant productivities.
Entrapment techniques are widely used for microorganism sta-
bilization and allow reuse of biocatalyst. Different agarose (2%, 3%,
Supplementary data
4
% and 5%) and polyacrylamide (15%, 20% and 25%) concentrations
were assayed for G. stearothermophilus immobilization as previously
described by Rivero and col.13 The minimum matrix percentage for
preventing microorganism release into the reaction medium was
assessed, being 4% and 25% the optimum percentages for agarose
and polyacrylamide immobilization, respectively. This thermophilic
microorganism was successfully immobilized in agarose and polya-
crylamide, obtaining 70% (at 6 h) and 61% (at 24 h) of 6ChPurdRib
conversion, respectively. It was observed that the immobilized bio-
catalysts required longer time than free microorganisms to reach
successful conversion values and it is well known that this differ-
References and notes
1.
Ikejiri, M.; Ohshima, T.; Kato, K.; Toyama, M.; Murata, T.; Shimotohno, K.;
Maruyama, T. Nucleic Acids Symp. Ser. (Oxf). 2007, 439.
2. Ikejiri, M.; Saijo, M.; Morikawa, S.; Fukushi, S.; Mizutani, T.; Kurane, I.;
Maruyama, T. Bioorg. Med. Chem. Lett. 2007, 17, 2470.
3
.
.
Pankiewicz, K. W.; Goldstein, B. M. In ACS Symposium Series; Society, A. C., Ed.;
American Chemical Society: Washington, DC, 2003; Vol. 839, p 1.
Narayanasamy, J.; Pullagurla, M. R.; Sharon, A.; Wang, J.; Schinazi, R. F.; Chu, C.
K. Antiviral Res. 2007, 75, 198.
4
1
4
5. Trelles, J. A.; Valino, A. L.; Runza, V.; Lewkowicz, E. S.; Iribarren, A. M. Biotechnol.
Lett. 2005, 27, 759.
ence is related to diffusion restrictions of these matrices. Finally,
an agarose matrix was selected for subsequent tests.
6
.
Bzowska, A.; Kulikowska, E.; Shugar, D. Pharmacol. Ther. 2000, 88, 349.
7. Almendros, M.; Berenguer, J.; Sinisterra, J. V. Appl. Environ. Microbiol. 2012, 78,
128.
G. stearothermophilus immobilized in agarose was stable for
more than 6 months in storage conditions (4 °C) and could be re-
used at least 70 times without significant loss of activity (about
3
8.
Trelles, J. A.; Fernández-Lucas, J.; Condezo, L. A.; Sinisterra, J. V. J. Mol. Catal. B:
Enzym. 2004, 30, 219.
9
0% retained activity) reaching 379 mg/L of 6ChPurdRib while free
9. Hamamoto, T.; Okuyama, K.; Noguchi, T.; Midorikawa, Y. Biosci. Biotechnol.
Biochem. 1997, 61, 272.
microorganisms were stable at 4 °C for 10 days and lost their